Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.2M Sell
21,570
-411
-2% -$80.6K 0.63% 23
2026
Q2
$6.63M Sell
21,981
-549
-2% -$109K 1.03% 17
2026
Q1
$3.32M Buy
22,530
+250
+1% +$36.6K 0.59% 27
2025
Q4
$2.71M Sell
22,280
-910
-4% -$107K 0.49% 31
2025
Q3
$2.5M Buy
23,190
+470
+2% +$43.8K 0.46% 36
2025
Q2
$2.04M Buy
22,720
+13,530
+147% +$1.02M 0.42% 40
2025
Q1
$625K Buy
+9,190
New +$662K 0.14% 85

Other funds holding KLAC

Harfst & Associates's KLAC Position: Q3 2026 in Review

Harfst & Associates reduced its KLA (KLAC) stake by 1.9% in Q3 2026, selling an estimated $80.6K and leaving 21,570 shares worth $4.2M. The position accounts for 0.63% of the portfolio, ranked #23.

Harfst & Associates first reported a position in KLAC in Q1 2025 and has held it in 7 quarters since. The position peaked at $6.63M in Q2 2026. 637 funds tracked by Wall St. Rank hold KLAC as of Q3 2026.

  • Harfst & Associates held 21,570 shares of KLA worth $4.2M as of Q3 2026.
  • Harfst & Associates sold 411 KLA shares in Q3 2026, an estimated $80.6K.
  • KLA made up 0.63% of Harfst & Associates's portfolio in Q3 2026, its #23 holding.
  • Harfst & Associates first reported a position in KLA in Q1 2025 and has held it in 7 quarters since.
  • Harfst & Associates's KLA position peaked at $6.63M in Q2 2026.
  • 637 funds tracked by Wall St. Rank held KLA as of Q3 2026.

Based on Harfst & Associates's 13F filing for Q3 2026, filed 20 Oct 2026.